Alira Health’s COVID-19 Response

News
Published on:
April 4, 2020

Throughout the COVID-19 pandemic, the Alira Health team has worked closely with our partners throughout the healthcare ecosystem to help support the community and get resources into the hands of those that need it most. Our work includes:

Mary McNamara-Cullinane

Just-in-time regulatory support

Our regulatory team, led by Mary McNamara-Cullinane, has been working closely with our clients and FDA on several fronts, including:

  • One Emergency Use Authorization to wean patients off ventilators is pending at FDA
  • Two ventilator accessory Emergency Use Authorizations
  • One remote patient monitoring system Emergency Use Authorization
  • Additional Emergency Use Authorizations for disinfectants and sanitizers are currently pendin

In addition, Mary is on two national task forces providing regulatory guidance for respirator and mask manufacturers.

Led by David Uffer, Senior Partner and VP of MedTech and Deepak Sahu, Partner, the Alira Health team has worked closely with partners across the healthcare ecosystem to provide:

David Uffer

Support across the supply chain

  • Supply chain reinforcement by connecting hospitals, suppliers, and governments to critical resources, including PPE and ventilators.
  • Support in establishing a PPE factory in India by connecting funding and technology with regional officials. This factory has been scaling up to produce more than 100,000 pairs of gloves and gowns.
  • Collaboration with the CEO of a Massachusetts hospital to connect the hospital’s innovation center with manufacturing partners for PPE technologies.
Deepak Sahu

Analysis and operational assistance

  • Introductions of an N95 respirator technology to potential manufacturers and investors.
  • Partnership with experienced industry professionals (who developed HIV screening protocols) to develop COVID-19 screening protocols. Looking past the current crisis, the team is also looking at how screening should be considered long-term.
  • Helping a low-cost ventilator company to scale up. The company is connected with several Massachusetts universities and has seen positive clinical results.

If you need help with your own COVID-19 relief work, please contact us to discuss how we can help support your efforts.

Related news

Publications May 27, 2022
The Impact of Chip Shortage on the MedTech Sector and RAS Players
Discover the three factors driving the chip shortage, the impact, and what’s next for Robotic and MedTech industry at large.
CDMO MedTech Robotcs
Events May 19, 2022
DIA 2022 Global Annual Meeting
We are pleased to announce that we will be joining DIA 2022 Global Annual Meeting as exhibitors and delegates.
Biometrics Clinical Regulatory
News May 11, 2022
Alira Health Acquires RedCrow, an Equity Crowdfunding Platform for Healthcare Startups
We acquired RedCrow, an alternative investment platform that provides individual investors with easy access to expert-vetted healthcare start-ups. The financial terms of the transaction(...)
MedTech Patient Engagement Pharma
Events May 9, 2022
7e Journée start-up innovantes du dispositif médical
Clinical Digital Health Market Access MedTech Research & Development
Uncategorized May 6, 2022
U.S. and European Clinical Development for Asian MedTech Startups
This webinar will focus on the U.S. FDA and EU MDR/IVDR regulatory pathways and strategies for medical device startups based in the Asia Pacific.
Clinical MedTech
Uncategorized April 13, 2022
U.S. and European Regulatory Strategies for Asian MedTech Startups
This webinar will focus on the U.S. FDA and EU MDR/IVDR regulatory pathways and strategies for medical device startups based in the Asia Pacific.
MedTech Regulatory
Publications April 8, 2022
Cheat Sheet: MDCG Guidance on Medical Device Classification
Assigning the proper class to a medical device (MD) is one of the most important activities carried out by a manufacturer. Read Alira Health's cheat sheet MDCG Guidance on Medical Device(...)
MedTech Regulatory
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.